AC Immune SA’s $50 Million Common Shares Offer

Homburger advised Jefferies LLC and Leerink Partners LLC on the deal.AC Immune SA, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here